title: Reply to: "Transarterial therapies for hepatocellular carcinoma (HCC): a long way towards standardization".
authors.forename: Joong-Won
authors.initials: JW
authors.lastname: Park
authors.forename: Hyun Beom
authors.initials: HB
authors.lastname: Kim
authors.forename: In Joon
authors.initials: IJ
authors.lastname: Lee
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001557:Benzenesulfonates / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D016461:Chemoembolization, Therapeutic / Q000379:methods*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male; D011725:Pyridines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D011725:Pyridines